JAPAN BIO PRODUCTS CO LTD has a total of 12 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are BIOCRINE AB, NORTHERN SYDNEY LOCAL HEALTH DISTR and TAIZHOU GUOKEHUAWU BIOMEDICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 3 | |
#3 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Diagnosis and surgery | |
#7 | Animal care | |
#8 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Kaku Taiichi | 7 |
#2 | Yamaguchi Shumpei | 5 |
#3 | Nakamura Takahiro | 4 |
#4 | Akitsu Masashi | 4 |
#5 | Inoue Shinjiro | 3 |
#6 | Tohda Chihiro | 3 |
#7 | Hirano Eiichi | 3 |
#8 | Morinaga Tetsuo | 3 |
#9 | Miyazaki Hiroyuki | 3 |
#10 | Kadota Yoshiharu | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019244354A1 | Cannula device | |
WO2019244355A1 | Cannula | |
US2019358287A1 | Methods for ameliorating memory impairment in a memory disorder caused by neuronal cell death or Abeta aggregation using a peptide | |
WO2014208381A1 | Hepatocyte-proliferating agent | |
WO2015166555A1 | Tear fluid secretion promoter, and prophylactic/therapeutic agent for dry eye associated with decrease in tear fluid secretion | |
WO2014077289A1 | Anticancer agent | |
US2015148350A1 | Drug for preventing/treating ocular disease |